Physician profile
Stephen May
NPI 1689850216
$5,858.11
in general payments reported to CMS, 2019-2025
8 companies · $2,670 in 2025
The $2,670 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $392 · 2020: $1,641 · 2021: $299 · 2022: $344 · 2023: $456 · 2024: $55.76 · 2025: $2,670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,940 · Food and Beverage: $1,242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,940.11 |
| Food and Beverage | $1,241.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,561.83 | 2019-2025 | Aveir, Amplatzer Amulet, Confirm Rx |
| Boston Scientific Corporation | $706.19 | 2019-2025 | Ingevity+, General - Therapies, Ingevity Mri |
| Biosense Webster, INC. | $190.55 | 2019-2023 | Carto 3 |
| Medtronic, INC. | $161.37 | 2022-2024 | Cobalt Dr Mri Surescan |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $124.12 | 2019-2025 | Lifevest |
| Cardiva Medical, INC. | $56.19 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $37.06 | 2024-2025 | Eliquis |
| Pfizer INC. | $20.80 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen May listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.